These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 6277194

  • 1. Criteria toward the definition of nonmetastatic gestational trophoblastic disease after hydatidiform mole.
    Kohorn EI.
    Am J Obstet Gynecol; 1982 Feb 15; 142(4):416-9. PubMed ID: 6277194
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY, Saxena BB, Landesman R.
    Obstet Gynecol; 1977 Aug 15; 50(2):172-81. PubMed ID: 195242
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the criteria used to make the diagnosis of nonmetastatic gestational trophoblastic neoplasia.
    Kohorn EI.
    Gynecol Oncol; 1993 Feb 15; 48(2):139-47. PubMed ID: 8381374
    [Abstract] [Full Text] [Related]

  • 5. Change in human chorionic gonadotropin in gestational trophoblastic disease observed during the course of chemotherapy.
    Huang SC, Hsieh CY, Ouyang PC.
    J Formos Med Assoc; 1991 Jan 15; 90(1):53-8. PubMed ID: 1679110
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia.
    Rotmensch J, Rosenshein NB, Block BS.
    Gynecol Oncol; 1988 Jan 15; 29(1):82-6. PubMed ID: 2448190
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI.
    Gynecol Oncol; 2000 Jul 15; 78(1):39-42. PubMed ID: 10873407
    [Abstract] [Full Text] [Related]

  • 15. Human chorionic gonadotropin (hCG) beta-core fragment is produced by degradation of hCG or free hCG beta in gestational trophoblastic tumors: a possible marker for early detection of persistent postmolar gestational trophoblastic disease.
    Okamoto T, Matsuo K, Niu R, Osawa M, Suzuki H.
    J Endocrinol; 2001 Dec 15; 171(3):435-43. PubMed ID: 11739009
    [Abstract] [Full Text] [Related]

  • 16. Successful resolution of persistent trophoblastic disease after partial mole with the EMA-CO regimen.
    Dgani R, Zalel Y, Biran H, Blickstein I, Caspi B, Weissman A, Shoham Z.
    Eur J Obstet Gynecol Reprod Biol; 1994 Mar 31; 54(1):77-9. PubMed ID: 7519153
    [Abstract] [Full Text] [Related]

  • 17. Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study).
    Curry SL, Schlaerth JB, Kohorn EI, Boyce JB, Gore H, Twiggs LB, Blessing JA.
    Am J Obstet Gynecol; 1989 Apr 31; 160(4):805-9; discussion 809-11. PubMed ID: 2540654
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemistry in the diagnosis of the gestational trophoblastic disease.
    Lösch A, Kainz C.
    Acta Obstet Gynecol Scand; 1996 Sep 31; 75(8):753-6. PubMed ID: 8906012
    [Abstract] [Full Text] [Related]

  • 19. [Hydatidiform mole, trophoblastic tumor/choriocarcinoma].
    Luschin-Ebengreuth G, Petru E, Pickel H.
    Gynakol Geburtshilfliche Rundsch; 1992 Sep 31; 32 Suppl 1():125-6. PubMed ID: 1337488
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of gestational trophoblastic tumors.
    Hansen LA, Clayton BD.
    Drug Intell Clin Pharm; 1984 Sep 31; 18(7-8):569-76. PubMed ID: 6086260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.